Stocktoria
Zoetis Inc. ZTS
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2013-02-01
Zoetis Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% |
| FCF margin | 24.1% | 24.8% | 19.0% | 16.4% | 22.3% |
| Return on assets | 17.3% | 17.5% | 16.4% | 14.2% | 14.7% |
| Return on equity | 78.3% | 51.3% | 46.9% | 48.0% | 44.8% |
| Debt / equity | 2.65× | 1.08× | 1.31× | 1.49× | 1.45× |
| Current ratio | 3.12 | 1.75 | 3.36 | 2.37 | 3.86 |
| Revenue growth | 2.3% | 8.3% | 5.7% | 3.9% | 16.5% |
Source: SEC EDGAR filings · CIK 0001555280 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.